Page 27 - Biological E News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biological E partners with Canadian firm to manufacture mRNA vaccines in India Biological E partners with Canadian firm to manufacture mRNA vaccines in India 02 June 2021 | News With a minimum production capacity of 600 million doses in 2022 and a target capacity of 1 billion doses Image credit- shutterstock.com Canadian firm Providence Therapeutics Holdings Inc. and Hyderabad-based Biological E have announced the execution of a term sheet, that sets forth the material terms for a definitive licensing and collaboration agreement. It also outlines the terms for sale by Providence of u...

We curate for you all the Covid-19-related developments and stories of the day worth reading

Biological E -- India's next Serum, Bharat Biotech of COVID-19 vaccine The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum. PB Jayakumar | June 2, 2021 | Updated 23:07 IST Providence will provide necessary technology transfer for Biological E to manufacture mRNA vaccines in India. The oldest Indian private vaccine maker, Hyderabad-based Biological E Limited, is emerging as a domestic powerhouse of COVID-19 vaccine manufacturing following its latest deal with Canada-based biotech company Providence Therapeutics...

India News: Biopharma player Biological E has joined hands with Canadian player Providence Therapeutics Holdings Inc for licencing the latter’s mRNA vaccine PTX-C

Read more about Biological E ties up with Canadian firm Providence for mRNA Covid vaccine on Business Standard. The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech